SanBio is a pharmaceutical company that engages in the research and development of regenerative medicines for the treatment of neurological disorders.
Business Model:
Revenue: $5.8M
Employees: 11-50
Address: St. Luke Tower 28F
City: Tokyo
State: tōkyō prefecture
Zip: 104-0044
Country: JP
SanBio is a pharmaceutical company that engages in the research and development of regenerative medicines for the treatment of neurological disorders.
Contact Phone:
Contact Email:
Listed Exchange:
Tokyo Stock Exchange
IPO Date:
4/8/2015
Ticker Symbol:
4592
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|